Menu Search
Equities

Merit Medical Systems Inc

MM3:DUS

Merit Medical Systems Inc

Actions
  • Price (EUR)95.00
  • Today's Change1.50 / 1.60%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 18:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Its segments include cardiovascular and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer (OEM). Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures. Its product portfolio of medical devices and accessories used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its electrophysiology and cardiac rhythm management portfolio includes steerable and other specialty technologies.

  • Revenue in USD (TTM)1.33bn
  • Net income in USD120.04m
  • Incorporated1987
  • Employees6.95k
  • Location
    Merit Medical Systems Inc1600 West Merit Park WaySOUTH JORDAN 84095United StatesUSA
  • Phone+1 (801) 253-1600
  • Fax+1 (801) 253-1652
  • Websitehttps://www.merit.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		MMSI:NSQ since
announced		Transaction
value
Cook Medical LLC-Lead Management BusinessDeal completed17 Sep 202417 Sep 2024Deal completed3.11%210.00m
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.